US 12,114,664 B2
Salmonella typhimurium bacteriophage STP-2 and use thereof for inhibiting proliferation of Salmonella typhimurium
Seong Jun Yoon, Seoul (KR); Soo Youn Jun, Seoul (KR); Jee Soo Son, Seoul (KR); Hyoun Rok Paik, Incheon (KR); Beom Seok Kim, Seoul (KR); and Sang Hyeon Kang, Seoul (KR)
Assigned to INTRON BIOTECHNOLOGY, INC., Gyeonggi-Do (CN)
Appl. No. 17/043,847
Filed by Intron Biotechnology, Inc., Gyeonggi-do (KR)
PCT Filed Feb. 19, 2019, PCT No. PCT/KR2019/001942
§ 371(c)(1), (2) Date Sep. 30, 2020,
PCT Pub. No. WO2019/198925, PCT Pub. Date Oct. 17, 2019.
Claims priority of application No. 10-2018-0041975 (KR), filed on Apr. 11, 2018.
Prior Publication US 2021/0054345 A1, Feb. 25, 2021
Int. Cl. C12N 7/00 (2006.01); A01N 63/40 (2020.01); A23K 10/16 (2016.01); A23L 2/52 (2006.01); A23L 33/10 (2016.01); A61K 35/76 (2015.01); A61P 31/04 (2006.01)
CPC A01N 63/40 (2020.01) [A23K 10/16 (2016.05); A23L 2/52 (2013.01); A23L 33/10 (2016.08); A61K 35/76 (2013.01); A61P 31/04 (2018.01); C12N 7/00 (2013.01); A23V 2002/00 (2013.01); C12N 2795/10321 (2013.01); C12N 2795/10331 (2013.01); C12N 2795/10332 (2013.01)] 2 Claims
 
1. A method of preventing and treating a disease caused by Salmonella Typhimurium, comprising:
administering to an animal other than a human a composition comprising, as the active ingredient, a Siphoviridae bacteriophage STP-2 which has an ability to kill Salmonella Typhimurium and a genome represented by a sequence as set forth in SEQ ID NO: 1, and is deposited as accession number KCTC 12853BP.